^
Association details:
Biomarker:No biomarker
Cancer:Cutaneous Melanoma
Drug:paclitaxel (Bcl2 inhibitor, Tubulin polymerization promoter)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Cutaneous melanoma: Recommended cytotoxic agents…Other agents include dacarbazine, paclitaxel, albumin-bound paclitaxel…